Stein A and Forman SJ. Allogeneic transplantation for ALL in adults. Bone Marrow Transplant 41(5): 439-46, 2008.

Nakamura R, Auayporn N, Smith DD, Palmer J, Sun JY, Schriber J, Pullarkat V, Parker P, Rodriguez R, Stein A, Rosenthal J, Wang S, Karanas C, Gaal K, Senitzer D and Forman SJ. Impact of graft cell dose on transplant outcomes following unrelated donor allogeneic peripheral blood stem cell transplantation: higher CD34+ cell doses are associated with decreased relapse rates. Biol Blood Marrow Transplant 14(4): 449-57, 2008.

Wang SR, Nademanee A, Qian DJ, Dagis A, Park HS, Fridey J, Smith E, Snyder D, Somlo G, Stein A, Rosenthal J, Falk P, Kogut N, Palmer J, Gaal K, Kim Y, Bhatia R, Yuan S, Kay C, Weiss L and Forman S. Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation. Transfusion 47(12): 2207-2216, 2007.

Nakamura R, Rodriguez R, Palmer J, Stein A, Naing A, Tsai N, Chang K, Slovak ML, Bhatia R, Spielberger R, Kogut N, Pullarkat V, Kirschbaum M, Forman SJ and O'Donnell MR. Reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation with fludarabine and melphalan is associated with durable disease control in myelodysplastic syndrome. Bone Marrow Transplantation 40(9): 843-850, 2007.

Bhatia S, Francisco L, Carter A, Sun CL, Baker KS, Gurney JG, McGlave PB, Nademanee A, O'Donnell M, Ramsay NKC, Robison LL, Snyder D, Stein A, Forman SJ and Weisdorf DJ. Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study. Blood 110(10): 3784-3792, 2007.

Wong JYC, Liu A, Schultheiss T, Popplewell L, Stein A, Rosenthal J, Forman S and Somlo G Targeted total marrow irradiation using 3D image guided tomographic intensity modulated radiation therapy: An alternative to standard TBI. Biology of Blood and Marrow Transplantation 12(2): 91-92, 2006.

Wong JYC, Liu A, Schultheiss T, Popplewell L, Stein A, Rosenthal J, Essensten M, Forman S and Somlo G Targeted total marrow irradiation using three-dimensional image-guided tomographic intensity-modulated radiation therapy: An alternative to standard total body irradiation. Biology of Blood and Marrow Transplantation 12(3): 306-315, 2006.

Wong, J.Y.C., Liu, A., Schultheiss, T., Popplewell, L., Stein, A., Rosenthal, J., Essensten, M., Forman, S.J., Somlo, G. Targeted total marrow irradiation using three-dimensional image-guided tomographic intensity-modulated radiation therapy: An alternative to standard total body irradiation. Biology of Blood and Marrow Transplantation, 12:306, 2006.

Nademanee, A., Forman, S.J., Molina, A., Fung, H., Smith, D., Dagis, A., Kwok, C., Yamauchi, D., Anderson, A., Falk, P., Krishnan, A., Kirschbaum, M., Kogut, N., Nakamura, R., O’Donnell, M., Parker, P., Popplewell, L., Pullarkat, V., Rodriguez, R., Sahebi, F., Smith, E., Snyder, D., Stein, A., Spielberger, R., Zain, J., White, C., and Raubitschek, A. A phase ½ trial of high-dose yttrium-90-ibritumomab tiuxetan in combination with high-dose etoposide and cyclophosphamide followed by autologous stem cell transplantation in patients with poor-risk or relapsed non-Hodgkin lymphoma. Blood, 106:2896, 2005.

Bhatia, S., Robison, L., Francisco, L., Carter, A., Liu, Y., Grant, M., Baker, K.S., Fung, H., Gurney, J.G, McGlave, P., Nademanee, A., Ramsay, N.K., Stein, A., Weisdorf, D.J. and Forman, S.J. Late mortality in survivors of autologous hermaopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study. Blood, 105:4215-22, 2005.

Snyder DS, Stein A, O’Donnell MR, Gaal K, Slovak ML, Forman SJ. Philadelphia Chromosome-Positive acute Lymphoblastic Leukemia secondary to Chemoradiotherapy for Ewing Sarcoma. Report of two Cases and Concise Review of the Literature. American Journal of Hematology, 78(1): 74-78 2005

Nademanee A, Forman S, Molina A, Fung H, Smith D, Dagis A, Kwok C, Yamauchi D, Anderson AL, Falk P, Krishnan A, Kirschbaum M, Kogut N, Nakamura R, O’Donnell M, Parker P, Popplewell, L, Pullarkat V, Rodriguez R, Sahebi F, Smith E, Snyder D, Stein A, Spielberger R, Zain J, White C, Raubitschek A. A Phase 1/2 Trial of High-dose Yttrium-90-Ibritumomab Tiuxetan in combination with high-dose Etoposide and Cyclophosphamide followed by Autologous Stem Cell Transplantation in Patients with Poor-risk or Relapsed non-Hodgkin Lymphoma, Blood 106(8) 2896-2902, 2005

Bhatia S, Robinson LL, Francisco L, Carter A, Liu Y, Grant M, Baker KS, Fung H, Gurney JG, McGlave, PB, Nademanee A, Ramsay, NKC, Stein A, Weisdorf, DJ, Forman SJ. Late Mortality in Survivors of Autologous Hematopoietic Cell Transplantation: Report from the Bone Marrow Transplant Survivor Study. Blood 105 (11): 4215-4222, 2005

Lopez F, Parker P, Nademanee A, Rodriguez R, Al-Kadimi Z, Bhatia R, Cohen S, Falk P, Fung H, Kirschbaum M, Krishnan A, Kogut N, Molina R, Nakamura R, O’Donnell M, Popplewell L, Pullarkat V, Rosenthal J, Sahebi F, Smith E, Snyder D, Somlo G, Spielberger R, Stein A, Sweetman R, Zain J, Forman S. Efficacy of mycophenolate mofetil in the treatment of chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation 11:307-313, 2005.

Snyder D, Stein A, O’Donnell MR, Gaal K, Slovak ML, Forman SJ. Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Secondary to Chemoradiotherapy for Ewing’s Sarcoma. A Report of Two Cases and a Review of the Literature. Accepted by Am J Hematol 2004

Rodriguez R, Parker P, Nademanee A, Smith D, O’Donnell MR, Stein A, Snyder DS, Fung HC, Krishnan AY, Popplewell L, Cohen S, Somlo G, Angelopoulou M, Al-Kadhimi Z, Falk PM, Spielberger R, Kogut N, Sahebi F, Senitzer D, Slovak M, Schriber J, Forman SJ. Cyclosporine and Mycophenolate Mofetil prophylaxis with Fludarabine and melphalan conditioning for Unrelated Donor Transplantation: a Prospective Study of 22 patients with Hematologic malignancies. Bone Marrow Transplantation 33 (11): 1123-1129, 2004

Stein A, O’Donnell MR, Slovak ML, Snyder DS, Nademanee AP, Parker P, Molina A, Somlo G, Fung HC, Krishnan A, Rodriguez R, Spielberger RT, Wang S, Dagis A, Vora N, Arber, DA, Niland JC, Forman SJ. Interleukin-2 after Autologous Stem Cell Transplantation for Adult Patients with Acute Myeloid leukemia in First Complete Remission. Journal of Clinical Oncology, 21 (4): 615-623, 2003

Stein A, Nademanee A, O’Donnell MR, Lee J, Schmidt GM, Parker PM, Snyder DS, Smith EP, Somlo G, Margolin KA, Fahey J, Niland JC, Forman SJ. High dose Cytosine Arabinoside and Daunorubicin Induction therapy for Acute Myelogenous leukemia – results for 100 Consecutive Treated patients and Analysis of Adverse Prognostic Factors Impact on Achieving a Remission. Leukemia; 14: 1191-1196; 2003

Fung HC, Stein A, Slovak M, O’Donnell MR, Snyder D, Cohen S, Smith D, Krishnan A, Spielberger R, Bhatia R, Bhatia S, Falk P, Molina A, Nademanee A, Parker P, Rodriguez R, Rosenthal J, Sweetman R, Kogut N, Sahebi F, Popplewell L, Vora N, Somlo G, Margolin K, Chow W, Smith E, Forman SJ. A long-term follow up report on allogeneic stem cell transplantation for patients with primary refractory acute myelogenous leukemia: impact of Cytogenetic characteristics on transplantation outcome. Biol Blood Marrow Transplant 9(12):
766-771; 2003

Fung HC, Cohen S, Rodriguez R, Smith D, Krishnan A, Somlo G, Sahebi F, Senitzer D, O’Donnell MR, Stein A, Snyder D, Spielberger R, Bhatia R, Falk P, Molina A, Nademanee A, Parker P, Kogut N, Popplewell L, Vora N, Margolin K, Forman SJ. Reduced-intensity allogeneic stem cell transplantation for patients whose prior autologous stem cell transplantation for hematologic malignancy failed. Biol Blood Marrow Transplant 9(10): 649-656, 2003

Snyder D, Stein A, O’Donnell M, Gaal K, Slovak ML, Forman SJ. Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Secondary to Chemoradiotherapy for Ewing’s Sarcoma. A Report of Two Cases and a Review of the Literature. Submitted Cancer 2003

Arber D, Stein A, Carter N, Ikle D, Forman SJ, Slovak M. Prognostic impact of acute myeloid leukemia classification – importance of detection of recurring cytogenetic abnormalities and multilineage dysplasia on 5 year survival. Amer J Clin Path 119: 672-680, 2003

Stein A, O’Donnell M, Slovak M, Snyder D, Nademanee A, Parker P, Molina A, Somlo G, Kashyap A, Fung HC, Krishnan A, Rodriguez R, Popplewell L, Cohen S, Falk P, Kogut N, Sahebi F, Spielberger R, Wang S, Dagis A, Vora N, Arber D, Niland JC and Forman SJ. Interleukin–2 following autologous stem cell transplantation for adult patients with acute myeloid leukemia in first complete remission. J Clin Oncol 21:615-623; 2003


This is a partial list. Full publications list available upon request. Information on this page may be self-reported and is subject to change at any time. Last updated: 12/08.